Extracellular Vesicles: From Biomarkers to Therapeutic Tools

Area of Science:

• Biotechnology
• Cell Biology
• Medical Science

Background:

• Multicellular organisms rely on intercellular communication via direct contact or secreted molecules.
• Extracellular vesicles (EVs), including exosomes, represent a third, significant mechanism for cell-to-cell signaling.
• EVs are membranous vesicles (30-5000 nm) categorized by size and biogenesis (e.g., microvesicles, apoptotic bodies, ectosomes, exosomes).

Discussion:

• Protein profiles on EVs reflect the physiological state of their parent cells, establishing them as potential disease biomarkers.
• EVs, particularly exosomes, are valuable in liquid biopsy for diagnosing conditions like cancer and monitoring heart transplant rejection.
• The clinical applications of EVs are expanding due to advancements in liquid biopsy techniques.

Key Insights:

• EVs serve as ideal biomarkers due to their ability to carry cellular information, aiding in early disease detection.
• Extracellular vesicles can function as natural or engineered carriers for therapeutic agents, including cytoprotective or cytotoxic factors.
• EVs are pivotal in the advancement of 4P medicine (Predictive, Preventive, Personalized, Participatory).

Outlook:

• Future research will likely focus on refining EV isolation and characterization for robust clinical applications.
• Engineered EVs offer novel therapeutic strategies for regenerative medicine and targeted cancer therapies.
• The integration of EV-based diagnostics and therapeutics aligns with the growing importance of personalized medicine.